Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Assets Average (2016 - 2025)

Regenxbio has reported Assets Average over the past 11 years, most recently at $489.1 million for Q4 2025.

  • Quarterly results put Assets Average at $489.1 million for Q4 2025, down 0.7% from a year ago — trailing twelve months through Dec 2025 was $489.1 million (down 0.7% YoY), and the annual figure for FY2025 was $459.5 million, down 11.63%.
  • Assets Average for Q4 2025 was $489.1 million at Regenxbio, down from $553.1 million in the prior quarter.
  • Over the last five years, Assets Average for RGNX hit a ceiling of $1.1 billion in Q1 2022 and a floor of $478.5 million in Q1 2025.
  • Median Assets Average over the past 5 years was $686.6 million (2023), compared with a mean of $716.3 million.
  • Biggest five-year swings in Assets Average: soared 87.8% in 2021 and later fell 29.66% in 2023.
  • Regenxbio's Assets Average stood at $957.1 million in 2021, then dropped by 10.3% to $858.5 million in 2022, then fell by 29.66% to $603.9 million in 2023, then decreased by 18.44% to $492.6 million in 2024, then fell by 0.7% to $489.1 million in 2025.
  • The last three reported values for Assets Average were $489.1 million (Q4 2025), $553.1 million (Q3 2025), and $536.0 million (Q2 2025) per Business Quant data.